LEXICON PHARMACEUTICALS, INC. (LXRX) Free cash flow 2016–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$67.9MFY2025 · since FY2016: -$175.9M → -$67.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$67.9M | +62.3% |
| FY2024 | -$179.8M | -10.7% |
| FY2023 | -$162.4M | -80.1% |
| FY2022 | -$90.2M | -2.2% |
| FY2021 | -$88.2M | +38.3% |
| FY2020 | -$143.1M | -225.8% |
| FY2019 | $113.7M | +176.5% |
| FY2018 | -$148.7M | +19.9% |
| FY2017 | -$185.6M | -5.6% |
| FY2016 | -$175.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LXRX financial trends
LXRX RevenueLXRX Net incomeLXRX Net marginLXRX Gross profitLXRX Gross marginLXRX Operating incomeLXRX Operating marginLXRX Operating cash flowLXRX Capital expendituresLXRX Return on equityLXRX Stock buybacksLXRX Dividends paidLXRX Total assetsLXRX Total liabilitiesLXRX Shareholders’ equityLXRX overview →